Atara Biotherapeutics (ATRA) came out with a quarterly loss of $2.93 per share versus the Zacks Consensus Estimate of a loss of $3.77. This compares to loss of $16.50 per share a year ago. These ...
How to use Atara Biotherapeutics Inc. ATRA as a Forecasting Tool ...
The Taliban’s spokesperson announced that Barat Shah Agha Nadim, head of the Afghanistan Telecommunications Regulatory ...
Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93. Atara Biotherapeutics ...
THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $21.9 million in its third quarter. On a per-share basis, the Thousand Oaks, ...
Zacks.com on MSN14h
Yatra Online, Inc. (YTRA) Reports Break-Even Earnings for Q2Yatra Online, Inc. (YTRA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures ...
Atara(ATRA)发布Q3财报，2024财年前三财季累计收入9618.70万美元，去年同期累计收入为432.10万美元，同比增长2126.04%。 2024财年前三财季累计净亏损7271.00万美元，去年同期累计净亏损为2.16亿美元，同比缩小66.29%。 本财年累计基本每股收益为-11.34美元，去年同期为-51.27美元。 公司所属行业为生物科技。 Atara Biotherapeuti ...
Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback